Author:
Ishiguro Akihiro,Yagi Satomi,Uyama Yoshiaki
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Genetics
Reference23 articles.
1. Uyama, Y., Ishiguro, A., Nakamura, H. & Toyoshima, S. Use of Biomarker in Drug Development-Japanese Perspectives, Predictive Approaches in Drug Discovery and Development 269–287 (John Wily & Sons, Inc.: Hoboken, New Jersey, 2012).
2. Maliepaard, M., Nofziger, C., Papaluca, M., Zineh, I., Uyama, Y., Prasad, K. et al. Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective. Nat. Rev. Drug. Discov. 12, 103–115 (2013).
3. Sawyers, C. L. The cancer biomarker problem. Nature 452, 548–552 (2008).
4. Institute of Medicine of the National Academies. Genome Based Therapeutics: Targeted Drug Discovery and Development: Workshop Summary, (The National Academies Press: Washington D.C., 2012).
5. Otsubo, Y., Ishiguro, A. & Uyama, Y. Regulatory perspective on remaining challenges for utilization of pharmacogenomics-guided drug developments. Pharmacogenomics 14, 195–203 (2013).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献